1. A world-first treatment based on an oncolytic virus allows a child to overcome retinal cancer

    The treatment, developed by researchers at Institut de Recerca Sant Joan de Déu, SJD Barcelona Children's Hospital and the biotechnology company VCN Biosciences has succeeded in preventing the child from going completely blind.

  2. Sant Joan de Déu Research Institute recognized as CERCA center

    The Sant Joan de Déu Research Institute (IRSJD) has been recognized by the board of trustees of the Institution for Research Centers in Catalonia (CERCA) as a CERCA centre.

  3. Gene crucial for growth of Ewing sarcoma uncovered

    Researchers at the Institut de Recerca Sant Joan de Déu in collaboration with those at Centre for Genomic Regulation have discovered that RING1B is a critical gene for the development of Ewing sarcoma, a rare type of developmental cancer that presents in bones and soft tissues.

  4. Institut de Recerca Sant Joan de Déu and ICFO create a joint lab to improve neonatal and paediatric health care

    The new joint laboratory will advance the use and development of photonic technologies to understand, diagnose, monitor and treat paediatric diseases.

  5. Dr Maria Rubio awarded a scientific excellence grant from the European Research Council (ERC)

    This financial award will fund an intervention in several primary care centres in Catalonia and is designed to encourage people with diabetes and cardiovascular disease to begin and comply with the pharmacological treatments as prescribed by their physician.

  6. Reproduce various stages of Ewing's sarcoma in mice

    Researchers at Institut de Recerca Sant Joan de Déu reproduce various stages of Ewing's sarcoma in mice to explain its resistance to medication.

  7. The european ImmunAID project starts its clinical phase

    The ImmunAID project aims to develop new diagnostic signatures for systemic auto-inflammatory diseases (SAID). Ultimately, the aim is to offer better care for these rare disease patients. Systemic auto-inflammatory diseases (SAID) are a complex and poorly understood group of rare diseases.

  8. Gate2Brain, the “key” to transporting drugs into the brain and improving their effectiveness

    Gate2Brain technology is based on a research line developed at IRB Barcelona and breakthroughs made jointly with the University of Barcelona and the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children’s Hospital.

  9. Care robotics can help patients with Duchenne muscular dystrophy (DMD)

    An IRSJD research team develop a robotic wheelchair helps to improve the physical condition of people with Duchenne muscular dystrophy.